GLP-1A - Coding and Documentation Considerations

March 5, 2025

What is GLP-1A?

By Robin Friday RN, MHA, CCS, CCDS, CCDS-O, CDIP,

AHIMA-Approved CDI Trainer

Recent statistics from Kaiser show that over 15 million adults

(6% of the adult population) in the US are currently taking a GLP-1 agonist.

Chances are you recently reviewed the medical record of a

patient who's taking Ozempic, Wegovy, or Mounjaro.

Also for you ...

Do you have questions or comments? We appreciate your thoughtful feedback!

Visit us at www.LibmanEducation.com or contact us.

Be in the know! Follow us for exclusive content:

As a premier provider of professional development for Health Information Management (HIM) and Revenue Cycle Management (RCM) professionals, Libman Education provides training and resources for individuals and teams working to strengthen the revenue cycle of leading healthcare organizations.

Libman Education, Inc.

PO Box 341, Bedford, MA 01730-0341

www.libmaneducation.com

info@libmaneducation.com

(978) 369-7180